Waters Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Udit Batra

Algemeen directeur

US$8.7m

Totale compensatie

Percentage CEO-salaris	12.6%
Dienstverband CEO	4.2yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	3.5yrs
Gemiddelde ambtstermijn bestuur	3.6yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Udit Batra's beloning veranderd ten opzichte van Waters's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 28 2024	n/a	n/a	US$623m
Jun 29 2024	n/a	n/a	US$596m
Mar 30 2024	n/a	n/a	US$604m
Dec 31 2023	US$9m	US$1m	US$642m
Sep 30 2023	n/a	n/a	US$653m
Jul 01 2023	n/a	n/a	US$675m
Apr 01 2023	n/a	n/a	US$689m
Dec 31 2022	US$9m	US$1m	US$708m
Oct 01 2022	n/a	n/a	US$697m
Jul 02 2022	n/a	n/a	US$702m
Apr 02 2022	n/a	n/a	US$705m
Dec 31 2021	US$9m	US$1m	US$693m
Oct 02 2021	n/a	n/a	US$695m
Jul 03 2021	n/a	n/a	US$660m
Apr 03 2021	n/a	n/a	US$616m
Dec 31 2020	US$6m	US$285k	US$522m

Compensatie versus markt: De totale vergoeding ($USD 8.74M ) Udit } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de BR markt ($USD 5.71M ).

Compensatie versus inkomsten: De vergoeding van Udit is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Udit Batra (53 yo)

4.2yrs

Tenure

US$8,742,180

Compensatie

Dr. Udit Batra, PhD, has been the President, Chief Executive Officer and Director at Waters Corporation since September 1, 2020. Dr. Batra served as Chief Executive Officer of Life Science business of Merc...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Udit Batra	President	4.2yrs	US$8.74m	geen gegevens
Amol Chaubal	Senior VP & CFO	3.5yrs	US$2.66m	0.0022% R$ 2.7m
Jianqing Bennett	Senior Vice President of TA Instruments Division & Waters Clinical Business Unit	3.5yrs	US$2.11m	0.0047% R$ 5.7m
Christos Ross	Senior Vice President of Global Operations	2.3yrs	geen gegevens	geen gegevens
Caspar Tudor	Director of Investor Relations	no data	geen gegevens	geen gegevens
Keeley Aleman	Senior VP	5.1yrs	US$2.05m	0.0034% R$ 4.1m
Kristen Garvey	Vice President of Corporate Communications	5.8yrs	geen gegevens	geen gegevens
Patrick Conway	Interim Vice President of Human Resources	less than a year	geen gegevens	geen gegevens
Daniel Rush	Senior Vice President of Strategy & Transformation	3.8yrs	geen gegevens	geen gegevens
Robert Carpio	Senior Vice President of Waters Division	less than a year	geen gegevens	0.0038% R$ 4.6m
John Lynch	Treasurer	no data	geen gegevens	geen gegevens

3.5yrs

Gemiddelde duur

50yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van WATC34 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.5 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Udit Batra	President	4.2yrs	US$8.74m	geen gegevens
Linda Baddour	Independent Director	6.2yrs	US$334.86k	0% R$ 0
Christopher Kuebler	Independent Director	18.5yrs	US$328.86k	0.025% R$ 30.4m
Richard Fearon	Independent Director	1.7yrs	US$256.04k	0.0028% R$ 3.4m
Mark Vergnano	Independent Director	2yrs	US$312.36k	0.0082% R$ 10.0m
Daniel Brennan	Independent Director	2yrs	US$321.36k	0.0028% R$ 3.5m
Pearl Huang	Independent Director	3.8yrs	US$322.36k	0.0043% R$ 5.2m
Flemming Ornskov	Independent Chairman	7.4yrs	US$480.36k	0% R$ 0
Wei Jiang	Independent Director	3.3yrs	US$307.86k	0.0033% R$ 4.0m
Heather Knight	Director	less than a year	geen gegevens	0.00028% R$ 343.5k

3.6yrs

Gemiddelde duur

66yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van WATC34 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.6 jaar).

Waters Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

Waters Corporation, Annual General Meeting, May 23, 2024

Waters Corporation Announces Resignation of Jonathan Pratt as Senior Vice President of the Waters Division

Waters Corporation Announces Executive Changes

Waters Corporation Appoints Dan Brennan and Mark Vergnano to Board of Directors

Waters Corporation, Annual General Meeting, May 24, 2022

Waters Corporation Announces Resignation of John Ballbach from the Board of Directors

Recent updates

Waters Corporation Raises Earnings Guidance for the Full Year of Fiscal Year Ending December 31, 2024

Waters Corporation Raises Earnings Guidance for the Full Year of Fiscal Year Ending December 31, 2024

Waters Corporation Announces New Bioseparations Tools Accelerate and Improve Development of Rna-Based Vaccines and Therapies Using LC-MS Analysis

Waters Corporation Introduces TA Instruments Discovery Core Rheometer

Waters Corporation to Report Q2, 2024 Results on Jul 31, 2024

Waters Corporation New Rapid Screening-DSC Enables Up to 24x Faster Thermal Stability Testing at Ultra-Low Sample Volumes for Antibody Drugs

Waters Corporation Provides Earnings Guidance for the Second Quarter and Full Year of 2024

Waters Corporation Accelerates the Development of Gene-Based Therapeutics with New GTxResolve Premier SEC Columns

Waters Corporation, Annual General Meeting, May 23, 2024

Waters Corporation Provides Earnings Guidance for the First Quarter and Full-Year 2024

Waters Corporation Announces Resignation of Jonathan Pratt as Senior Vice President of the Waters Division

Waters Corporation Launched OligoWorks SPE Workflow and Kits

Waters Corporation Introduces DynaPro™? ZetaStar™? Instrument from its Wyatt Technology™? Portfolio for Nanoparticle Analysis

Waters Corporation Provides Earnings Guidance for the Third Quarter and Full Year 2023

Waters Corporation Launches XBridge Premier GTx BEH SEC Columns for Gene Therapy Applications

Waters Corporation Boosts Resolution and Triples Scan Speed of Select Series MRT for Metabolomics and MS Imaging

Waters Corporation Provides Earnings Guidance for the Second Quarter of 2023 and Fiscal Year 2023

Waters Corporation Provides Earnings Guidance for the First Quarter of 2023 and Fiscal Year 2023

Waters Corporation Announces Waters_Connect™ System Monitoring

Waters Corporation Announces Executive Changes

Waters Corporation Appoints Dan Brennan and Mark Vergnano to Board of Directors

Waters Introduces New PFAS Quantitation Workflow Enabled by Enhancements to Waters_Connect Informatics Platform

Waters Corporation Provides Earnings Guidance for the Fourth Quarter and Full Year of 2022

Waters Automates Solid Phase Extraction of Biological, Food and Environmental Samples with Andrew+ Pipetting Robot

Waters Extends Capabilities of Flagship Ta Instruments Rheometer for Efficient and Repeatable Powder Analysis

Waters Corporation Provides Earnings Guidance for the Third Quarter Ending October 1, 2022 and Full Year Ending December 31, 2022

Waters Corporation to Report Q2, 2022 Results on Aug 02, 2022

Waters Corporation(NYSE:WAT) dropped from Russell 1000 Value-Defensive Index

Waters Corporation Introduces High Resolution Mass Spectrometry Products and Software to Accelerate Drug Development

Waters Corporation Provides Earnings Guidance for the Quarter Ending July 2, 2022 and Full Year Ending December 31, 2022

Waters Corporation, Annual General Meeting, May 24, 2022

Waters Corporation Announces Resignation of John Ballbach from the Board of Directors

Waters Introduces Xevo TQ Absolute

Waters Corporation Provides Earnings Guidance for the First Quarter Ending April 2, 2022 and Year Ending December 31, 2022

Waters Corporation Introduces the Waters™ BioAccord™ System

Waters Corporation Provides Earnings Guidance for the Third Quarter and Full Year 2021

Waters Corporation Introduces TRIOS AutoPilot Software

Waters Corp. Introduces the Waters Arc Premier System

Waters Corporation Introduces the Sars-Cov-2 Lc-Ms Kit (Ruo) to Advance Clinical Research of Infectious Diseases

Waters Corporation Provides Earnings Guidance for the Three Months Ended July 3, 2021 and for the Full Year Ended December 31, 2021

Waters Corporation Introduces A New Peptide Multi-Attribute Method Workflow for the Waters BioAccord LC-MS System

Waters Corporation Improves Ease and Reliability of Small Molecule Analysis with ACQUITY RDa Detector

Waters and TetraScience Partner to Deliver New Levels of Data Access and Insights with Empower Data Science Link

Waters Corporation Introduces the OttoTM SPEcialist Positive Pressure Manifold

Waters Corporation's APGC-MS/MS System Accepted for Advanced Dioxin and Furan Analysis Following USEPA Approval of SGS AXYS Method 16130

Waters Corporation Appoints Pearl S. Huang to Board of Directors

Waters Corporation Announces CFO Changes

Megadalton Solutions, Inc. Announces Expansion of Collaboration with Waters Corporation

Waters Corporation Gives More Laboratories Access to Mass Spectrometry with Rapid, Easy, and Compact RADIAN ASAP System

Waters Corporation Introduces Acquity Premier Columns

Waters Corporation (NYSE: WAT) signed an agreement to acquire rheology instruments and services business of Rheometric Scientific, Inc. for $23 million.

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Leiderschapsteam

Gemiddelde duur

Gemiddelde leeftijd

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd